Pulmonx Corp Share Price

NASDAQ: LUNG

Small Cap

$1.55

-0.03

(-1.90%)

as on September 18, 2025 at 1:29 am IST

$₹

Pulmonx Corp Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$1.54
Day's Price Range
$1.63
$1.55
0.65%
Downside
5.16%
Upside
52 Week's Low
52 Week's High
$1.47
52-Week Price Range
$9.37
$1.55
5.16%
Downside
504.52%
Upside

Pulmonx Corp share price movements today

Previous Close: $1.58
Open: $1.60
Volume: 272.0K
Day's Low - High: $1.54 - $1.63
52 Week Low - High: $1.47 - $9.37

Pulmonx Corp Historical Returns

1 Month Return: + 1.92 %
3 Month Return: -41.33 %
1 Year Return: -80.56 %
3 Year Return: -91.3 %
5 Year Return: 0 %

Pulmonx Corp Stock Fundamentals & Key Indicators

Check Pulmonx Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$64.4M

EPS (TTM)

-1.5467

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.95

Industry PE ratio

-3.9281873111782475

P/B Ratio

PEG Ratio

EBITDA

-53.9M

Revenue (TTM)

90.5M

Profit Margin

-62.88%

Return On Equity TTM

127074000.00%

Pulmonx Corp Stock Valuation

Track how Pulmonx Corp P/E has moved over time to understand its valuation trends.

Pulmonx Corp in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Today (-4.95x)

September 17, 2025

Industry (-3.93x)

September 17, 2025

Highest (0.00x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: -4.95x

Pulmonx Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pulmonx Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Pulmonx Corp	BUY	$64.4M	NA	-4.95	-62.88%
Boston Scientific Corp.	BUY	$146.7B	149.51%	58.92	13.55%
Stryker Corporation	BUY	$144.0B	78.01%	50.02	12.25%
Abbott Laboratories	BUY	$231.1B	24.47%	16.66	32.43%
Medtronic Plc	BUY	$120.8B	-12.63%	26.02	13.63%

See all

Stock Returns calculator for Pulmonx Corp Stock including INR - Dollar returns

The Pulmonx Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Pulmonx Corp investment value today

Current value as on today

₹23,547

Returns

₹76,453

(-76.45%)

Returns from Pulmonx Corp Stock

₹81,051 (-81.05%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Pulmonx Corp Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Pulmonx Corp. Average target price of $6.75

Pulmonx Corp Share Price Target

Get share price movements and forecasts by analysts on Pulmonx Corp.

What analysts predicted

77.04%UPSIDE

Target Price

$6.75

Current Price

$1.55

Analyzed by

11 Analysts

Target

$6.75

Pulmonx Corp target price $6.75, a slight upside of 77.04% compared to current price of $1.55. According to 11 analysts rating.

Pulmonx Corp Stock's Interest Amongst Investors

Search interest for Pulmonx Corp Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:8% versus previous 30 day period

Pulmonx Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	14	17	17	19	18	20	20	23	22	23
Gross Profit	10	12	13	14	13	15	15	17	16	17
Operating Income	-16	-16	-15	-13	-14	-13	-14	-15	-14	-14
EBITDA	-14	-14	-13	-12	-12	-13	-12	-18	-14	-13
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-15	-16	-14	-13	-13	-15	-13	-13	-14	-14
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-15	-16	-14	-13	-13	-15	-14	-13	-14	-15
Net Profit Margin	-109.12%	-94.19%	-84.33%	-72.04%	-72.92%	-73.74%	-69.38%	-55.44%	-64.11%	-63.59%

Pulmonx Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	-	20	32	32	48	53	68	83
Gross Profit	0	0	-	12	22	21	35	39	50	62
Operating Income	-2	-2	-5	-15	-17	-32	-47	-58	-61	-57
EBITDA	-	-	-	-15	-16	-28	-46	-55	-55	-50
Interest Expense	-	-	-	2	2	3	0	1	3	3
Depreciation	-	-	-	0	0	0	0	1	1	1
Income Before Tax	-2	-2	-5	-18	-20	-32	-48	-58	-60	-55
Income Tax Expense	-	-	-	0	0	0	0	0	0	0
Net Income	-2	-2	-5	-18	-20	-32	-48	-58	-60	-56
Net Profit Margin	-14398.30%	-31539.27%	0.00%	-92.38%	-63.52%	-98.47%	-100.51%	-109.80%	-88.60%	-67.30%

Pulmonx Corp Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-16	-14	-13	-13	-15	-14	-13	-14	-15
Operating Cash Flow	-7	-8	-8	-11	-5	-7	-6	-13	-3
Investing Cash Flow	0	0	-2	-2	0	6	14	16	5
Financing Cash Flow	0	0	0	0	0	0	0	0	0
Change in Cash	-8	-6	-11	-13	-6	0	7	3	0

Pulmonx Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-5	-18	-20	-32	-48	-58	-60	-56
Operating Cash Flow	-2	-4	-18	-20	-30	-41	-45	-37	-31
Investing Cash Flow	0	0	0	-14	12	-46	-4	-2	17
Financing Cash Flow	1	5	12	45	234	4	2	21	1
Change in Cash	0	0	-5	10	217	-83	-46	-18	-12

Global Institutional Holdings in Pulmonx Corp

Funds	Holdings
FMR Inc	13.3%
PRIMECAP Management Company	13.29%
Morgan Stanley - Brokerage Accounts	8.58%
BlackRock Inc	6.84%
Vanguard Group Inc	5.6%

See all

Insights on Pulmonx Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 22.53M → 23.85M (in $), with an average increase of 5.5% per quarter
NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 137.4% return, outperforming this stock by 228.8%
NO EFFECT
Against Peers
In the last 1 year, Boston Scientific Corp. has given 19.9% return, outperforming this stock by 100.6%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -13.17M → -15.17M (in $), with an average decrease of 7.3% per quarter
NEGATIVE IMPACT
Price Dip
In the last 3 months, LUNG stock has moved down by -41.7%

About Pulmonx Corp

pulmonx is focused on developing life-changing technologies that improve the lives of patients suffering from lung disease. the company’s first commercial products address emphysema, a form of copd (chronic obstructive pulmonary disease) and the largest unmet medical need in pulmonology. with emphysema, breathing becomes increasingly more difficult as the disease progresses. today in the u.s., advanced emphysema patients have no available alternatives but lung volume reduction surgery, which is associated with high morbidity and mortality, and lung transplantation, which is limited by the availability of donor organs. pulmonx has developed the zephyr endobronchial valve (ebv) therapy, a non-surgical, investigational approach to treating emphysema. the minimally invasive zephyr valve is a tiny, one-way valve designed to reduce the volume of the diseased regions of the lung by blocking airflow, in order to improve breathing and increase activity levels. no surgery is involved in the simp

Organisation	Pulmonx Corp
Headquarters	700 Chesapeake Drive, Redwood City, CA, United States, 94063
Industry	Health Technology
CEO	Mr. Steven S. Williamson
E-voting on shares	Click here to vote

Key Management of Pulmonx Corp

Name	Title
Ms. Marcee M. Maroney	Vice President of Marketing
Ms. Sarah Huber	Vice President of Sales (U.S.)
Ms. Lisa Paul	Chief People Officer
Mr. Jérôme Erath	Senior VP & GM of International
Mr. John B. McKune	VP of Finance & Corporate Controller
Mr. Sri Radhakrishnan	Chief Technical Officer
Mr. Mehul Joshi	Chief Financial Officer
Mr. David A. Lehman J.D.	General Counsel & Secretary
Mr. Geoffrey Beran Rose	Chief Commercial Officer
Mr. Steven S. Williamson	CEO, President & Director

FAQs

What is Pulmonx Corp share price today?

Pulmonx Corp share price today is $1.55 as on September 18, 2025 at 1:29 am IST at the close of the market. Pulmonx Corp share today touched a day high of $1.63 and a low of $1.54.

What is the 52 week high and 52 week low for Pulmonx Corp share?

Pulmonx Corp share touched a 52 week high of $9.37 on February 20, 2025 and a 52 week low of $1.47 on August 14, 2025. Pulmonx Corp stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $1.55,which is 83.46% down from its 52 week high and 5.44% up from its 52 week low.

What is Pulmonx Corp's market capitalisation today?

Pulmonx Corp market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Pulmonx Corp Stock (LUNG) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pulmonx Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pulmonx Corp Shares that will get you 0.9677 shares as per Pulmonx Corp share price of $1.55 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Pulmonx Corp Stock (LUNG) from India?

Indian investors can start investing in Pulmonx Corp (LUNG) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 3:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Pulmonx Corp stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 3:37 am IST). Based on Pulmonx Corp share’s latest price of $1.55 as on September 18, 2025 at 1:29 am IST, you will get 6.4516 shares of Pulmonx Corp. Learn more about fractional shares .